11.90
price up icon1.19%   0.14
after-market Handel nachbörslich: 11.90
loading

Finanzdaten der Oric Pharmaceuticals Inc-Aktie (ORIC)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
5.78%
34.55
36.67 39.06 32.72 39.57
Operating Income/Loss
5.78%
-34.55
-36.67 -39.06 -32.72 -39.57
Nonoperating Income/Loss
0.93%
4.046
4.084 2.709 2.697 3.263
Income/Loss From Continuing Operations Before Tax
6.39%
-30.50
-32.59 -36.35 -30.02 -36.31
Income/Loss From Continuing Operations After Tax
6.39%
-30.50
-32.59 -36.35 -30.02 -36.31
Net Income/Loss
6.39%
-30.50
-32.59 -36.35 -30.02 -36.31
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
94.96%
4.9848
98.95 78.13 71.04 0.3103
Diluted Average Shares
94.96%
4.9848
98.95 78.13 71.04 0.3103
Basic Earnings Per Share
18.18%
-0.27
-0.33 -0.47 -0.42 -0.51
Diluted Earnings Per Share
18.18%
-0.27
-0.33 -0.47 -0.42 -0.51
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):